{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T18:49:31Z","timestamp":1791053371624,"version":"4.1.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T00:00:00Z","timestamp":1338508800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T00:00:00Z","timestamp":1338508800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Biogen-Idec Corporation"},{"DOI":"10.13039\/100005202","name":"Muscular Dystrophy Association","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100005202","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100008335","name":"Arizona Biomedical Research Commission","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100008335","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100009797","name":"Barrow Neurological Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100009797","id-type":"DOI","asserted-by":"crossref"}]},{"name":"NIH","award":["RO1AI083294"],"award-info":[{"award-number":["RO1AI083294"]}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jni-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.1016\/j.jneuroim.2012.03.011","type":"journal-article","created":{"date-parts":[[2012,4,13]],"date-time":"2012-04-13T09:32:08Z","timestamp":1334309528000},"page":"9-15","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["Antibody to \u03b14 integrin suppresses natural killer cells infiltration in central nervous system in experimental autoimmune encephalomyelitis"],"prefix":"10.1016","volume":"247","author":[{"given":"Yan","family":"Gan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruolan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Bomprezzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fu-Dong","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jneuroim.2012.03.011_bb0005","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1111\/j.1600-065X.2006.00465.x","article-title":"Natural killer cells in viral infection: more than just killers","volume":"214","author":"Andoniou","year":"2006","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.jneuroim.2012.03.011_bb0195","author":"Biogen Idec"},{"key":"10.1016\/j.jneuroim.2012.03.011_bb0015","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1146\/annurev.immunol.17.1.189","article-title":"Natural killer cells in antiviral defense: function and regulation by innate cytokines","volume":"17","author":"Biron","year":"1999","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.jneuroim.2012.03.011_bb0020","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1001\/archneur.65.12.noc80051","article-title":"Decrease in the numbers of dendritic cells and CD4+ T cells in cerebral perivascular spaces due to natalizumab","volume":"65","author":"del Pilar Martin","year":"2008","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.jneuroim.2012.03.011_bb0025","doi-asserted-by":"crossref","first-page":"3798","DOI":"10.4049\/jimmunol.134.6.3798","article-title":"Natural killer (NK) cells are present in mice with severe combined immunodeficiency (SCID)","volume":"134","author":"Dorshkind","year":"1985","journal-title":"J. Immunol."},{"key":"10.1016\/j.jneuroim.2012.03.011_bb0030","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1126\/science.272.5258.50","article-title":"The instructive role of innate immunity in the acquired immune response","volume":"272","author":"Fearon","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.jneuroim.2012.03.011_bb0035","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/j.coi.2009.09.012","article-title":"Natural killer cells in human autoimmunity","volume":"21","author":"Flodstr\u00f6m-Tullberg","year":"2009","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.jneuroim.2012.03.011_bb0040","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S095279150200002X","article-title":"Natural killer cells and viral infections","volume":"15","author":"French","year":"2003","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.jneuroim.2012.03.011_bb0045","doi-asserted-by":"crossref","first-page":"384","DOI":"10.4049\/jimmunol.146.1.384","article-title":"Human natural killer cells express VLA-4 and VLA-5, which mediate their adhesion to fibronectin","volume":"146","author":"Gismondi","year":"1991","journal-title":"J. Immunol."},{"key":"10.1016\/j.jneuroim.2012.03.011_bb0050","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1084\/jem.20092749","article-title":"Central nervous system (CNS)-resident natural killer cells suppress Th17 responses and CNS autoimmune pathology","volume":"207","author":"Hao","year":"2010","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jneuroim.2012.03.011_bb0055","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.jneuroim.2011.03.001","article-title":"Natalizumab therapy decreases surface expression of both VLA-heterodimer subunits on peripheral blood mononuclear cells","volume":"234","author":"Harrer","year":"2011","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2012.03.011_bb0060","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/S0167-5699(97)01149-3","article-title":"The immunoregulatory effects of NK cells \u2014 the role of TGF-\u03b2 and implications for autoimmunity","volume":"18","author":"Horwitz","year":"1997","journal-title":"Immunol. Today"},{"key":"10.1016\/j.jneuroim.2012.03.011_bb0065","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1096\/fj.05-5465com","article-title":"The neuronal chemokine CX3CL1\/fractalkine selectively recruits NK cells that modify experimental autoimmune encephalomyelitis within the central nervous system","volume":"20","author":"Huang","year":"2006","journal-title":"FASEB J."},{"key":"10.1016\/j.jneuroim.2012.03.011_bb0200","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/S1474-4422(11)70149-1","article-title":"Natalizumab treatment for multiple sclerosis: updated recommendations for patient selection and monitoring","volume":"10","author":"Kappos","year":"2011","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jneuroim.2012.03.011_bb0080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0165-5728(94)00165-K","article-title":"A monoclonal antibody to alpha 4 integrin suppresses and reverses active experimental allergic encephalomyelitis","volume":"58","author":"Kent","year":"1995","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2012.03.011_bb0075","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1212\/01.wnl.0000341766.59028.9d","article-title":"Effect of plasma exchange in accelerating natalizumab clearance and restoring leukocyte function","volume":"72","author":"Khatri","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2012.03.011_bb0085","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1056\/NEJMoa051782","article-title":"Progressive multifocal leukoencephalopathy complicating treatment with natalizumab and interferon beta-1a for multiple sclerosis","volume":"353","author":"Kleinschmidt-DeMasters","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jneuroim.2012.03.011_bb0090","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1056\/NEJMoa051847","article-title":"Progressive multifocal leukoencephalopathy in a patient treated with natalizumab","volume":"353","author":"Langer-Gould","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jneuroim.2012.03.011_bb0095","doi-asserted-by":"crossref","first-page":"6227","DOI":"10.4049\/jimmunol.178.10.6227","article-title":"CD24 on the resident cells of the central nervous system enhances experimental autoimmune encephalomyelitis","volume":"178","author":"Liu","year":"2007","journal-title":"J. Immunol."},{"key":"10.1016\/j.jneuroim.2012.03.011_bb0100","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1046\/j.1365-2567.2000.00994.x","article-title":"Expression and functional activity of the very late activation antigen-4 molecule on human natural killer cells in different states of activation","volume":"100","author":"Mac\u00edas","year":"2000","journal-title":"Immunology"},{"key":"10.1016\/j.jneuroim.2012.03.011_bb0105","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1002\/eji.1830250723","article-title":"A myelin oligodendrocyte glycoprotein peptide induces typical chronic experimental autoimmune encephalomyelitis in H-2b mice: fine specificity and T cell receptor V beta expression of encephalitogenic T cells","volume":"25","author":"Mendel","year":"1995","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.jneuroim.2012.03.011_bb0110","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1056\/NEJMoa020696","article-title":"A controlled trial of natalizumab for relapsing multiple sclerosis","volume":"348","author":"Miller","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jneuroim.2012.03.011_bb0115","doi-asserted-by":"crossref","first-page":"3126","DOI":"10.1093\/ndt\/13.12.3126","article-title":"Expression of VLA-4 on peripheral mononuclear cells in patients on chronic haemodialysis with carpal tunnel syndrome","volume":"13","author":"Ogino","year":"1998","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.jneuroim.2012.03.011_bb0125","doi-asserted-by":"crossref","first-page":"95","DOI":"10.4049\/jimmunol.143.1.95","article-title":"Role of natural killer cells as immune effectors in encephalitis and demyelination induced by Theiler's virus","volume":"143","author":"Paya","year":"1989","journal-title":"J. Immunol."},{"key":"10.1016\/j.jneuroim.2012.03.011_bb0120","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1056\/NEJMoa044397","article-title":"A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis","volume":"354","author":"Polman","year":"2006","journal-title":"NEJM"},{"key":"10.1016\/j.jneuroim.2012.03.011_bb0130","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1097\/CJI.0b013e3181acec1e","article-title":"IL-4 suppresses very late antigen-4 expression which is required for therapeutic Th1 T-cell trafficking into tumors","volume":"32","author":"Sasaki","year":"2009","journal-title":"J. Immunother."},{"key":"10.1016\/j.jneuroim.2012.03.011_bb0135","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.jneuroim.2007.09.006","article-title":"The role of natural killer cells in curbing neuroinflammation","volume":"191","author":"Segal","year":"2007","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2012.03.011_bb0140","series-title":"Nature killer cells","first-page":"373","article-title":"Nature killer cells in the central nervous system","author":"Shi","year":"2010"},{"key":"10.1016\/j.jneuroim.2012.03.011_bb0145","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.4049\/jimmunol.165.6.3099","article-title":"IL-18 directs autoreactive T cells and promotes autodestruction in the central nervous system via induction of IFN-gamma by NK cells","volume":"165","author":"Shi","year":"2000","journal-title":"J. Immunol."},{"key":"10.1016\/j.jneuroim.2012.03.011_bb0150","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.jneuroim.2011.02.010","article-title":"Novel mechanisms of immune modulation of natalizumab in multiple sclerosis patients","volume":"235","author":"Skarica","year":"2011","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2012.03.011_bb0155","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1002\/ana.20858","article-title":"Immune surveillance in multiple sclerosis patients treated with natalizumab","volume":"59","author":"St\u00fcve","year":"2006","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2012.03.011_bb0160","first-page":"511","article-title":"Adaptive immune features of natural killer cells","volume":"457","author":"Sun","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.jneuroim.2012.03.011_bb0165","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1084\/jem.177.1.155","volume":"177","author":"Takeda","year":"1993","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jneuroim.2012.03.011_bb0170","doi-asserted-by":"crossref","first-page":"2696","DOI":"10.4049\/jimmunol.174.5.2696","article-title":"Differential effects of IL-21 during initiation and progression of autoimmunity against neuroantigen","volume":"174","author":"Vollmer","year":"2005","journal-title":"J. Immunol."},{"key":"10.1016\/j.jneuroim.2012.03.011_bb0175","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1056\/NEJMe020157","article-title":"Alpha4 integrins as therapeutic targets in autoimmune disease","volume":"348","author":"von Andrian","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jneuroim.2012.03.011_bb0180","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1177\/1352458510383075","article-title":"Adhesion molecules are promising candidates to establish surrogate markers for natalizumab treatment","volume":"17","author":"Wipfler","year":"2011","journal-title":"Mult. Scler."},{"key":"10.1016\/j.jneuroim.2012.03.011_bb0185","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/356063a0","article-title":"Prevention of experimental autoimmune encephalomyelitis by antibodies against alpha 4 beta 1 integrin","volume":"356","author":"Yednock","year":"1992","journal-title":"Nature"},{"key":"10.1016\/j.jneuroim.2012.03.011_bb0190","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1084\/jem.186.10.1677","article-title":"Regulation of experimental autoimmune encephalomyelitis by natural killer (NK) cells","volume":"186","author":"Zhang","year":"1997","journal-title":"J. Exp. Med."}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572812000756?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572812000756?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T08:19:17Z","timestamp":1759047557000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165572812000756"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6]]},"references-count":38,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2012,6]]}},"alternative-id":["S0165572812000756"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2012.03.011","relation":{},"ISSN":["0165-5728"],"issn-type":[{"value":"0165-5728","type":"print"}],"subject":[],"published":{"date-parts":[[2012,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antibody to \u03b14 integrin suppresses natural killer cells infiltration in central nervous system in experimental autoimmune encephalomyelitis","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2012.03.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}